Glenmark Pharma Q2 Results Review; Can Company Achieve Margin Guidance? | VS Mani
Автор: ET Now
Загружено: 2023-11-15
Просмотров: 200
Описание:
Weak show from Glenmark Pharma in q2. Sales slipped below dollar 100 million. Exceptional legal costs weigh more. What are the major reason behind companies performance in the quarter. Glenmark's VS Mani joins us to discuss Q2 challenges, H2 outlook and launches in the pipeline
#glenmarkpharma #glenmarkq2 #glenmarkpharmaq2
Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ► https://goo.gl/SEjvK3
Subscribe Now To Our Network Channels :-
Times Now : http://goo.gl/U9ibPb
The NewsHour Debate : http://goo.gl/LfNgFF
To Stay Updated Download the Times Now App :-
Android Google Play : https://goo.gl/zJhWjC
Apple App Store : https://goo.gl/d7QBQZ
Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC
G+ - http://goo.gl/hYxrmj
Website - www.etnownews.com
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
